These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6592942)

  • 21. Clopidogrel/aspirin combination therapy in high-risk atrial fibrillation patients.
    Cardiovasc J Afr; 2009; 20(3):210. PubMed ID: 19575095
    [No Abstract]   [Full Text] [Related]  

  • 22. Adverse haematological effects of ticlopidine.
    Prescrire Int; 1998 Feb; 7(33):21. PubMed ID: 10183397
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ticlopidine-induced neutropenia].
    Balbir A; Odeh M; Atias D; Oliven A
    Harefuah; 1996 Jun; 130(12):822-4, 879. PubMed ID: 8885506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
    L'Allier PL; Aronow HD; Cura FA; Bhatt DL; Albirini A; Schneider JP; Topol EJ; Ellis SG
    Can J Cardiol; 2003 Aug; 19(9):1041-6. PubMed ID: 12915931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cholestatic icterus and agranulocytosis due to ticlopidine].
    Saint-Marc Girardin MF; Cordonnier C
    Gastroenterol Clin Biol; 1982; 6(8-9):716-7. PubMed ID: 7129024
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hematological toxicity of ticlopidine? (author's transl)].
    de Gramont A; Canuel C; Krulik M; Bauters F; Degos L; Marty M; Najean Y
    Nouv Rev Fr Hematol (1978); 1982; 24(1):35-7. PubMed ID: 7071010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cholestatic jaundice associated with ingestion of ticlopidine: apropos of the first 2 cases].
    Deschamps JP; Lassègue A; Ottignon Y; Vuitton D; Allemand H; Carayon P; Miguet JP
    Gastroenterol Clin Biol; 1982; 6(6-7):595-6. PubMed ID: 7117772
    [No Abstract]   [Full Text] [Related]  

  • 29. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K; Eisenberg MJ; Zhang X; Pilote L
    Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible bone-marrow suppression primarily involving granulopoiesis following the use of Ticlopidine.
    Quaglino D; Venturoni L; Cretara G; Ricciotti M
    Haematologica; 1982; 67(6):940-1. PubMed ID: 6819199
    [No Abstract]   [Full Text] [Related]  

  • 31. Post-approval adverse events of new and old anticoagulants.
    Hoffman KB; Demakas A; Erdman CB; Dimbil M
    BMJ; 2014 Mar; 348():g1859. PubMed ID: 24603571
    [No Abstract]   [Full Text] [Related]  

  • 32. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neutropenia induced by ticlopidine: a delayed onset case].
    Bellarosa I; Nargi L; Scarano V; Terracciano AM; Orlando V
    Recenti Prog Med; 2009 Jan; 100(1):27-30. PubMed ID: 19445279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug-induced platelet functional disorder].
    Kariya T
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):380-4. PubMed ID: 9833520
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Arq Bras Cardiol; 1983 Dec; 41(6):425-7. PubMed ID: 6678584
    [No Abstract]   [Full Text] [Related]  

  • 37. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kondo M
    Thromb Haemost; 1983 Jun; 49(3):190-2. PubMed ID: 6879507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin.
    Selleng K; Selleng S; Raschke R; Schmidt CO; Rosenblood GS; Greinacher A; Warkentin TE
    Am J Hematol; 2005 Mar; 78(3):188-92. PubMed ID: 15726594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
    Wallén H; Agren A; Nekludov M
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.